205 related articles for article (PubMed ID: 11272362)
1. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds.
Knapp FF; Guhlke S; Beets AL; Lin WY; Stabin M; Amols H; Weinberger J
Cardiovasc Radiat Med; 1999; 1(1):86-97. PubMed ID: 11272362
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorate: option for subsequent care after the use of liquid 188Re in a balloon catheter.
Kotzerke J; Fenchel S; Guhlmann A; Stabin M; Rentschler M; Knapp FF; Reske SN
Nucl Med Commun; 1998 Aug; 19(8):795-801. PubMed ID: 9751935
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of three rhenium-188 candidates for intravascular radiation therapy with liquid-filled balloons to prevent restenosis.
Lin WY; Tsai SC; Hsieh BT; Lee TW; Ting G; Wang SJ
J Nucl Cardiol; 2000; 7(1):37-42. PubMed ID: 10698233
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive study on the blockage of thyroid and gastric uptakes of 188Re-perrhenate in endovascular irradiation using liquid-filled balloon to prevent restenosis.
Lin WY; Hsieh JF; Tsai SC; Yen TC; Wang SJ; Knapp FF
Nucl Med Biol; 2000 Jan; 27(1):83-7. PubMed ID: 10755650
[TBL] [Abstract][Full Text] [Related]
5. 188Re-ethylene dicysteine: a novel agent for possible use in endovascular radiation therapy.
Das T; Banerjee S; Samuel G; Sarma HD; Ramamoorthy N; Pillai MR
Nucl Med Commun; 2000 Oct; 21(10):939-45. PubMed ID: 11130335
[TBL] [Abstract][Full Text] [Related]
6. Rhenium-188-Labeled DTPA: a new radiopharmaceutical for intravascular radiation therapy.
Hsieh BT; Hsieh JF; Tsai SC; Lin WY; Huang HT; Ting G; Wang SJ
Nucl Med Biol; 1999 Nov; 26(8):967-72. PubMed ID: 10708312
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry of rhenium-188 diethylene triamine penta-acetic acid for endovascular intra-balloon brachytherapy after coronary angioplasty.
Lee J; Lee DS; Kim KM; Yeo JS; Cheon GJ; Kim SK; Ahn JY; Jeong JM; Chung JK; Lee MC
Eur J Nucl Med; 2000 Jan; 27(1):76-82. PubMed ID: 10654151
[TBL] [Abstract][Full Text] [Related]
8. Automation of the synthesis of highly concentrated 188Re-MAG3 for intracoronary radiation therapy.
Oh SJ; Moon DH; Ha HJ; Park SW; Hong MK; Park SJ; Choi TH; Lim SM; Choi CW; Knapp FF; Lee HK
Appl Radiat Isot; 2001 Mar; 54(3):419-27. PubMed ID: 11214876
[TBL] [Abstract][Full Text] [Related]
9. Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases.
Lin WY; Lin CP; Yeh SJ; Hsieh BT; Tsai ZT; Ting G; Yen TC; Wang SJ; Knapp FF; Stabin MG
Eur J Nucl Med; 1997 Jun; 24(6):590-5. PubMed ID: 9169563
[TBL] [Abstract][Full Text] [Related]
10. Endovascular brachytherapy for the prevention of restenosis after angioplasty.
Kotzerke J; Hanke H; Höher M
Eur J Nucl Med; 2000 Feb; 27(2):223-36. PubMed ID: 10755730
[TBL] [Abstract][Full Text] [Related]
11. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
[TBL] [Abstract][Full Text] [Related]
12. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
13. [Production and therapeutic use of rhenium-186, 188--the future of radionuclides].
Vucina J; Han R
Med Pregl; 2003; 56(7-8):362-5. PubMed ID: 14587255
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
15. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
[TBL] [Abstract][Full Text] [Related]
16. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy.
Jeong JM; Knapp FF
Semin Nucl Med; 2008 Mar; 38(2):S19-29. PubMed ID: 18243839
[TBL] [Abstract][Full Text] [Related]
17. Simple new method for effective concentration of 188Re solutions from alumina-based 188W-188Re generator.
Guhlke S; Beets AL; Oetjen K; Mirzadeh S; Biersack HJ; Knapp FF
J Nucl Med; 2000 Jul; 41(7):1271-8. PubMed ID: 10914921
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
[TBL] [Abstract][Full Text] [Related]
19. Rhenium-188--a generator-derived radioisotope for cancer therapy.
Knapp FF
Cancer Biother Radiopharm; 1998 Oct; 13(5):337-49. PubMed ID: 10851424
[TBL] [Abstract][Full Text] [Related]
20. Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice.
Kinuya S; Yokoyama K; Tega H; Hiramatsu T; Konishi S; Yamamoto W; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
Jpn J Cancer Res; 1998 Aug; 89(8):870-8. PubMed ID: 9765625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
